Eun Ae Kang

8PUBLICATIONS
30CO-AUTHORS
AutoimmunityInnate immunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 31, 2023
Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy.

So Jung Han, Eun Ae Kang, Jihye Park

|Jul 17, 2022
Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease.

Eun Ae Kang, Jae Hee Cheon

|Jan 10, 2022
The Prognostic Value of Residual Nonrectal Inflammation in Ulcerative Colitis.

Eun Ae Kang

|Aug 23, 2021
Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn's Disease Recurrence.

Jongwook Yu, Hye Kyung Hyun, Jihye Park

|Mar 26, 2021
Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis.

Jongwook Yu, Jihye Park, Eun Ae Kang

|Mar 26, 2021
Long-term Outcomes after the Discontinuation of Anti-Tumor Necrosis Factor-α Therapy in Patients with Inflammatory Bowel Disease under Clinical Remission: A Korean Association for the Study of Intestinal Disease Multicenter Study.

Joo Hye Song, Eun Ae Kang, Soo-Kyung Park

Pageof 2

Frequent Collaborators

4 joint publications

Jae Hee Cheon

3 joint publications

Tae Il Kim

3 joint publications

Jae Jun Park

3 joint publications

Won Ho Kim